Next Article in Journal / Special Issue
Infrastructure and Educational Needs of Newborn Screening Short-Term Follow-Up Programs within the Southeast Regional Newborn Screening & Genetics Collaborative: A Pilot Survey
Previous Article in Journal
From Their Voices: Barriers to HIV Testing among Black Men Who Have Sex with Men Remain
Previous Article in Special Issue
When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives
Article Menu

Export Article

Open AccessArticle
Healthcare 2015, 3(4), 948-963; doi:10.3390/healthcare3040948

The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014

1
Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
2
Oregon Health Authority, Portland, OR 97232, USA
3
Georgia Department of Public Health, Atlanta, GA 30303-3142, USA
4
Michigan Department of Health and Human Services, Lansing, MI 48909, USA
These authors contributed equally to this work.
*
Author to whom correspondence should be addressed.
Academic Editor: Sampath Parthasarathy
Received: 31 August 2015 / Revised: 25 September 2015 / Accepted: 8 October 2015 / Published: 15 October 2015
(This article belongs to the Special Issue Implementation of Public Health Genomics)
View Full-Text   |   Download PDF [222 KB, uploaded 25 November 2015]   |  

Abstract

In 2011, the Division of Cancer Prevention and Control (DCPC), at the United States Centers for Disease Control and Prevention (CDC), released a three-year funding opportunity announcement (FOA) for a competitive, non-research cooperative agreement. The agreement enhanced the capacities of state health departments to promote the application of best practices for evidence-based breast cancer genomics through education, surveillance, and policy activities. The FOA required that applicants focus on activities related to hereditary breast and ovarian cancer (HBOC). The DCPC funded three states: Georgia, Michigan, and Oregon. Georgia was a first-time recipient of cancer genomics funding, whereas Michigan and Oregon had long standing activities in cancer genomics and had received CDC funding in the past. By the end of the funding period, each state had well-functioning and impactful state-based programs in breast cancer genomics. This article highlights the impact of a few key state activities by using CDC’s Science Impact Framework. There were challenges to implementing public health genomics programs, including the need to develop relevant partnerships, the highly technical nature of the subject matter, a lack of genetic services in certain areas, and the difficulty in funding genetic services. Georgia, Michigan, and Oregon have served as models for others interested in initiating or expanding cancer genomics programs, and they helped to determine what works well for promoting and integrating public health genomics into existing systems. View Full-Text
Keywords: genomics; genetic services; implementation; state health departments; BRCA; breast cancer; ovarian cancer; hereditary breast; ovarian cancer genomics; genetic services; implementation; state health departments; BRCA; breast cancer; ovarian cancer; hereditary breast; ovarian cancer
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Trivers, K.F.; Rodriguez, J.L.; Cox, S.L.; Crane, B.E.; Duquette, D. The Activities and Impact of State Programs to Address Hereditary Breast and Ovarian Cancer, 2011–2014. Healthcare 2015, 3, 948-963.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Healthcare EISSN 2227-9032 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top